Skip to content
bluejethealthcare.com
Home
About Us
At A Glance
Facilities
Board of Directors
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Notices
Investor Presentation
Stock Exchange Communication
Financial Information
Annual Return
Corporate Governance
Board Committees
Governance Policies
Prospectus / MOA / AOA
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
AGM / EGM
Menu
Home
About Us
At A Glance
Facilities
Board of Directors
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Notices
Investor Presentation
Stock Exchange Communication
Financial Information
Annual Return
Corporate Governance
Board Committees
Governance Policies
Prospectus / MOA / AOA
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
AGM / EGM
Financial Year 2024-25
Quarterly Results
Financials June 2024
Financials September 2023
Financial Year 2023-24
BRSR- 2023-24
Annual Report 2023-24
Quarterly Results
Financials March 2024
Financials December 2023
Financials September 2023
Financials June 2023
Financial Year 2022-23
Standalone Annual Report FY 22-23
Financial Year 2021-22
Standalone Annual Report FY 21-22
Financial Year 2020-21
Consolidated Annual Report FY 20-21
Standalone Annual Report FY 20-21
Scroll to Top
